Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
Anyone familiar with clinical research understands that paper-based patient assessments are a crucial yet challenging aspect of data gathering and analysis for both participants and sponsors.
Collecting patient-reported outcomes (PROs) through these assessments or diaries is essential for capturing the patient’s perspective. PROs also provide sponsors with invaluable insights into patient behavior, adverse events, and other essential clinical trial information. However, traditional paper-based methods for collecting this data are inefficient and fraught with issues.
In trials that utilize paper assessments, patients are instructed to fill them out at significant moments during their treatment. This might involve daily reflections on their well-being or noting down specific quantitative or qualitative data at times that matter during their day.
Patients are supposed to complete the assessments clearly and according to a set schedule. Yet, adherence to these guidelines is not guaranteed. Often, they might complete the forms all at once, perhaps just before their next trial visit, or they might fail to complete them at all. Such practices can lead to gaps in the clinical trial database, impede the timely access to data for sponsors, and compromise the reliability of this inherently subjective information.
Electronic Clinical Outcomes Assessment (eCOA) solutions can address many of these issues effectivelyeCOA solutions convert PROs into a digital format that gathers real-time feedback from patients about their condition, trial experience and the treatment's effect on their life quality. This offers numerous immediate advantages.
Transitioning to an eCOA solution is more in tune with patients' lifestyles, offering a more patient-focused data collection experience. To further improve this, many sponsors are adopting a BYOD eCOA strategy.
Contrary to some beliefs, sponsors do not always need to supply specialized devices for assessments. Allowing patients to use their own devices for eCOAs can boost engagement and still adhere to data security standards.
With BYOD, patients can begin logging data immediately after downloading the app. Since people are seldom without their phones, the eCOA becomes integrated into their daily routine, providing the flexibility to complete assessments anywhere. It also makes it more difficult to overlook reminders since their personal device is typically close at hand.
The eCOA applications are secure with password protection, and data is uploaded immediately after submission. Therefore, even if a patient misplaces their phone, they can resume data entry on a new device by simply reinstalling the app.
This approach is secure, cost-effective, and centered around the patient, simplifying trial participation for all parties.
Life science companies may hesitate to integrate new technologies into their clinical research processes, but the advantages of eCOAs are undeniable. Prioritizing patient-centricity is key for trial leaders, and patients now expect their trial experiences to be as streamlined as their everyday digital interactions. eCOAs deliver this convenience, benefiting all stakeholders.
To learn more about enhancing patient-centricity in your upcoming trial with an eCOA, contact us at ecoa@iqvia.com and speak with a specialist today.
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
Explore our Frequently Asked Questions (FAQ) page to learn more about general industry eCOA topics and also specific details about our IQVIA eCOA solution.
In these short demo videos, learn more about some of the key capabilities within the IQVIA eCOA platform including how to easily create an assessment, utilize the AI design tool, access automated screenshots and documentation, export/import translations, and view study data and reports.
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.